Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Observational × Ototoxicity × Clear all

Status

Sponsor Class

OTHER 5 OTHER_GOV 1 NETWORK 1

Study Type

Observational 1

Sponsor

Conditions

Leukemia 64 Breast Neoplasms 46 Lymphoma 30 Precursor Cell Lymphoblastic Leukemia-Lymphoma 27 Leukemia, Myeloid, Acute 24 Colorectal Neoplasms 24 Neoplasms 23 Sarcoma 20 Prostatic Neoplasms 18 Congenital Abnormalities 18 Lung Neoplasms 17 Carcinoma, Non-Small-Cell Lung 17 Ovarian Neoplasms 14 Neuroblastoma 14 Colonic Neoplasms 14 Rectal Neoplasms 13 Melanoma 13 Multiple Myeloma 12 Leukemia, Myelomonocytic, Acute 11 Leukemia, Megakaryoblastic, Acute 11 Leukemia, Lymphocytic, Chronic, B-Cell 11 Kidney Neoplasms 11 Head and Neck Neoplasms 11 Wilms Tumor 10 Squamous Cell Carcinoma of Head and Neck 10 Leukemia, Monocytic, Acute 10 Leukemia, Erythroblastic, Acute 10 HIV Infections 10 Osteosarcoma 9 Lymphoma, Follicular 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00458887 2017-03-13

Assessing Ear Damage in Young Cancer Patients Treated With Cisplatin

Children's Oncology Group

Ototoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡